Shortage reports
Actual shortage:
23 (15%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
125 (84%)
149
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (19%)
17 (74%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-PRAVASTATIN | 20MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-12-05 | 217378 |
| MINT-PRAVASTATIN | Resolved | 2017-10-26 | 2018-01-31 | 27157 | ||
| MINT-PRAVASTATIN | 10MG | TABLET TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217375 |
| MINT-PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-17 | 35501 |
| MINT-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-02-03 | 35498 |
| MINT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46030 |
| MINT-QUETIAPINE | 100MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46033 |
| MINT-QUETIAPINE | 200MG | TABLET | Resolved | 2018-04-16 | 2018-05-09 | 46038 |
| MINT-QUETIAPINE | 300MG | TABLET | Resolved | 2018-04-16 | 2018-04-18 | 46041 |
| MINT-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-10-31 | 217387 |
| MINT-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217390 |
| MINT-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-03-26 | 217393 |
| MINT-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-04-11 | 217396 |
| MINT-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-26 | 2025-04-11 | 217384 |
| MINT-RAMIPRIL | 15.0MG | CAPSULE | Resolved | 2020-08-19 | 2021-01-11 | 122510 |
| MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
| MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-08-22 | 2024-12-05 | 92275 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Actual shortage | 2025-03-18 | 2025-07-31 | 252950 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |